EUVIMEDEUVIMED entdecken
Open Access

Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling

Eduardo Frias-Anaya iD, Helios Gallego-Gutierrez iD, Brendan Gongol, Shantel Weinsheimer iD, Catherine Chinhchu Lai, Marco Orecchioni iD, Aditya Sriram, Cassandra M Bui, Bliss Nelsen iD, Preston Hale, Angela Pham, Robert Shenkar und 16 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-06 · 44 (6) · 1246-1264

DOI: 10.1161/atvbaha.123.320367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-06. Verfasst von Eduardo Frias-Anaya und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (E.F.-A., H.G.-G., C.C.L., C.M.B., B.N., P.H., A.P., H.S., M.G., O.A.M., M.H.G., M.A.L.-R.), University of California San Dieg…. Hauptthemen laut MEDLINE: Chemokine CX3CL1, CX3C Chemokine Receptor 1, Disease Models, Animal, Hemangioma, Cavernous, Central Nervous System. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Heterogeneity in the severity of cerebral cavernous malformations (CCMs) disease, including brain bleedings and thrombosis that cause neurological disabilities in patients, suggests that environmental, genetic, or biological factors act as disease modifiers. Still, the underlying mechanisms are not entirely understood. Here, we report that mild hypoxia accelerates CCM disease by promoting angiogenesis, neuroinflammation, and vascular thrombosis in the brains of CCM mouse models. METHODS: We used genetic studies, RNA sequencing, spatial transcriptome, micro–computed tomography, fluorescence-activated cell sorting, multiplex immunofluorescence, coculture studies, and imaging techniques to reveal that sustained mild hypoxia via the CX3CR1-CX3CL1 (CX3C motif chemokine receptor 1/chemokine [CX3C motif] ligand 1) signaling pathway influences cell-specific neuroinflammatory interactions, contributing to heterogeneity in CCM severity. RESULTS: Histological and expression profiles of CCM neurovascular lesions ( Slco1c1-iCreERT2;Pdcd10 fl/fl ; Pdcd10 BECKO ) in male and female mice found that sustained mild hypoxia (12% O 2 , 7 days) accelerates CCM disease. Our findings indicate that a small reduction in oxygen levels can significantly increase angiogenesis, neuroinflammation, and thrombosis in CCM disease by enhancing the interactions between endothelium, astrocytes, and immune cells. Our study indicates that the interactions between CX3CR1 and CX3CL1 are crucial in the maturation of CCM lesions and propensity to CCM immunothrombosis. In particular, this pathway regulates the recruitment and activation of microglia and other immune cells in CCM lesions, which leads to lesion growth and thrombosis. We found that human CX3CR1 variants are linked to lower lesion burden in familial CCMs, proving it is a genetic modifier in human disease and a potential marker for aggressiveness. Moreover, monoclonal blocking antibody against CX3CL1 or reducing 1 copy of the Cx3cr1 gene significantly reduces hypoxia-induced CCM immunothrombosis. CONCLUSIONS: Our study reveals that interactions between CX3CR1 and CX3CL1 can modify CCM neuropathology when lesions are accelerated by environmental hypoxia. Moreover, a hypoxic environment or hypoxia signaling caused by CCM disease influences the balance between neuroinflammation and neuroprotection mediated by CX3CR1-CX3CL1 signaling. These results establish CX3CR1 as a genetic marker for patient stratification and a potential predictor of CCM aggressiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CX3CL1CX3C Chemokine Receptor 1Disease Models, AnimalHemangioma, Cavernous, Central Nervous SystemSignal TransductionAnimalsFemaleHumansMaleMiceHypoxiaMice, Inbred C57BLMice, KnockoutNeovascularization, PathologicNeuroinflammatory Diseases

Stichwörter der Autor:innen

genetic markershemangioma, cavernous, central nervous systemhypoxianeuroinflammatory diseasesthromboinflammation

Substanzen

Chemokine CX3CL1CX3C Chemokine Receptor 1CX3CL1 protein, humanCx3cl1 protein, mouseCx3cr1 protein, mouseCX3CR1 protein, human

Autor:innen und Institutionen

  • Department of Medicine (E.F.-A., H.G.-G., C.C.L., C.M.B., B.N., P.H., A.P., H.S., M.G., O.A.M., M.H.G., M.A.L.-R.), University of California San Diego, La Jolla.
  • Department of Health Sciences, Victor Valley College, Victorville, CA (B.G.).
  • Institute for Integrative Genome Biology, 1207F Genomics Building, University of California, Riverside (B.G.).
  • Department of Anesthesia and Perioperative Care, Institute for Human Genetics, University of California, San Francisco (S.W., A.S., H.K.).
  • Division of Inflammation Biology, La Jolla Institute for Immunology, CA (M.O., K.L.).
  • Neurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago Medicine and Biological Sciences, IL (R.S., D.D., R.L., R.G., Y.L., A.S., I.A.A.).

ORCID-Profile: Eduardo Frias-Anaya, Helios Gallego-Gutierrez, Shantel Weinsheimer, Marco Orecchioni, Bliss Nelsen, Dorothy DeBiasse, Rhonda Lightle, Ying Li, Hao Sun, Monica Guma, Alexandre Dubrac, Omar A Mesarwi, Klaus Ley, Helen Kim, Issam A Awad, Miguel Alejandro Lopez-Ramirez

Förderung

  • NICHD NIH HHS
  • NHLBI NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • American Heart Association-American Stroke Association

Zitieren

APA

Frias-Anaya, E., Gallego-Gutierrez, H., Gongol, B., Weinsheimer, S., Lai, C. C., Orecchioni, M., Sriram, A., Bui, C. M., Nelsen, B., Hale, P., Pham, A., Shenkar, R., DeBiasse, D., Lightle, R., Girard, R., Li, Y., Srinath, A., Daneman, R., Nudleman, E., …, & Lopez-Ramirez, M. A. (2024). Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(6), 1246-1264. https://doi.org/10.1161/atvbaha.123.320367

Vancouver

Frias-Anaya E, Gallego-Gutierrez H, Gongol B, Weinsheimer S, Lai CC, Orecchioni M, et al. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(6):1246-1264. doi:10.1161/atvbaha.123.320367

BibTeX
@article{FriasAnaya2024,
  author = {Frias-Anaya, Eduardo and Gallego-Gutierrez, Helios and Gongol, Brendan and Weinsheimer, Shantel and Lai, Catherine Chinhchu and Orecchioni, Marco and Sriram, Aditya and Bui, Cassandra M and Nelsen, Bliss and Hale, Preston and Pham, Angela and Shenkar, Robert and DeBiasse, Dorothy and Lightle, Rhonda and Girard, Romuald and Li, Ying and Srinath, Abhinav and Daneman, Richard and Nudleman, Eric and Sun, Hao and Guma, Monica and Dubrac, Alexandre and Mesarwi, Omar A and Ley, Klaus and Kim, Helen and Awad, Issam A and Ginsberg, Mark H and Lopez-Ramirez, Miguel Alejandro},
  title = {Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  volume = {44},
  number = {6},
  pages = {1246--1264},
  doi = {10.1161/atvbaha.123.320367}
}
Kostenlos starten →